Search results for "malattie"

showing 10 items of 1963 documents

Variant GII.4 noroviruses in Italian children

2009

Objectives: Among human noroviruses (NoVs), a few genogroup II strains of genotype 4 (GII.4) are dominant worldwide. GII.4 NoVs evolve rapidly and in 2006 two new epidemic variants have been identified. To investigate the circulation of GII.4 NoV variants in Italy a sequence analysis was performed on NoV strains obtained from children hospitalized for sporadic viral gastroenteritis in Palermo. Methods: A total of 465 faecal specimens were collected from children (< 5 years) hospitalized from January 2005 to December 2006. The presence of NoVs was detected by RT-PCR using primers JV12/JV13, targeting the region A of the RNA-dependent RNA-polymerase (RdRp) gene. NoV strains were genotyped by …

NoroviruSettore MED/07 - Microbiologia E Microbiologia ClinicagenotypingItalySettore MED/17 - Malattie InfettiveGII.4 genotype
researchProduct

Norwegian (crusted) scabies of glans penis in an immunocompetent patien

2009

Norwegian (crusted) scabiesSettore MED/35 - Malattie Cutanee E Veneree
researchProduct

Erratum to: Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA

2016

The authors would like to change and use the correct name of M. Khaitov which is M. Kaitov on this manuscript. The authors have incorrectly used her other name during the finalization of this research. With this, the authors hereby publish the correct author names as presented above. © 2016 Serdi and Springer-Verlag France

Nutrition and DieteticsNutrition & DieteticsGeriatrics gerontologybusiness.industryMedicine (miscellaneous)Settore MED/10 - Malattie Dell'Apparato RespiratorioallergyFinalizationAsthmaAction (philosophy)Correct nameMedicineEngineering ethicsGeriatrics and GerontologybusinessQuality of Life Research
researchProduct

Valutazione dello stato nutrizionale

2008

Nutrizione anzianiSettore MED/10 - Malattie Dell'Apparato Respiratorio
researchProduct

RESTITUTIO AD INTEGRUM IN A CASE OF ONJ RELATED TO BEVACIZUMAB

2014

Aim. Bevacizumab is a humanized recombinant monoclonal antibody that blocks vascular endothelial growth factor (VEGF). The activity of VEGF is the ability to promote the vascular endothelial cells proliferation inducing the formation of new blood vessels. Bevacizumab is used in the treatment of selected advanced colon, lung, renal and central nervous system tumours and plays a developing role in the management of breast and ovarian cancers. It is also injected intraocularly for treatment of macular degeneration. Recently, bevacizumab has been reported as responsible of drug-related osteonecrosis of the jaw (ONJ), showing a histological pattern similar to bisphosphonate-related ONJ. Moreover…

ONJ BevacizumabSettore MED/28 - Malattie Odontostomatologiche
researchProduct

Early onset ONJ in patient treated with denosumab and bevacizumab: case report

2016

ONJ early onset denosumab bevacizumabSettore MED/28 - Malattie Odontostomatologiche
researchProduct

Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life

2021

Abstract Background and aims Severe asthma is burdened by frequent exacerbations and use of oral corticosteroids (OCS) which worsen patients’ health and increase healthcare spending. Aim of this study was to assess the clinical and economic effect of adding mepolizumab (MEP) for the treatment of these patients. Methods Patients >18 years old, referred to 8 asthma clinics, starting MEP between May 2017 and December 2018, were enrolled and followed-up for 12 months. Information in the 12 months before mepolizumab were collected retrospectively. The evaluation parameters included: OCS use, number of exacerbations/hospitalizations, concomitant therapies, comorbidity, and annual number of workin…

OR Odds RatioPediatricsSevere asthmaExacerbationAnti IL-5; Comorbidities; Mepolizumab; OCS; Pharmacoeconomics; Severe asthmagastroesophageal reflux diseaseSettore MED/10 - MALATTIE DELL'APPARATO RESPIRATORIOICS inhaled corticosteroidRate ratioOCS Oral Corticosteroidslaw.inventionComorbiditiesLAMA long acting muscarinic antagonist0302 clinical medicineRandomized controlled trialfractional nitric oxideInterquartile rangelawlong acting beta 2 agonistOdds RatioImmunology and AllergyRR Rate Ratio030223 otorhinolaryngologyPharmacoeconomicLOS Length of stayLOSIQRLAMAMEP MepolizumabORCISD Standard DeviationMEPPharmacoeconomicsACT Asthma Control TestComorbiditieCI Confidence Intervalsmedicine.druglcsh:Immunologic diseases. AllergyPulmonary and Respiratory Medicinemedicine.medical_specialtyinterquartile rangelong acting muscarinic antagonistImmunologyLABALABA long acting beta 2 agonistComorbidities Mepolizumab OCS Pharmacoeconomics Severe asthma Anti IL-5RRArticleRate Ratiochronic obstructive pulmonary disease03 medical and health sciencesPharmacoeconomicsOCS Oral CorticosteroidAsthma Control TestConfidence IntervalsFeNO fractional nitric oxideRCTs Randomized Controlled TrialmedicineCOPDGERD gastroesophageal reflux diseaseFeNOIQR interquartile rangeMepolizumabSDAsthmaRCTsOral Corticosteroidsbusiness.industryGERDmedicine.diseaseICS inhaled corticosteroidsACTComorbidityRandomized Controlled TrialsCI Confidence IntervalRCTs Randomized Controlled TrialsOCSCOPD chronic obstructive pulmonary disease030228 respiratory systemICSStandard DeviationLength of stayAnti IL-5inhaled corticosteroidslcsh:RC581-607businessMepolizumab
researchProduct

RUOLO DELL’OSAS E DELL’OBESITA’ NELLA PATOGENESI DELLE ALTERAZIONI INFIAMMATORIE, FUNZIONALI, METABOLICHE E CARDIOVASCOLARI IN PAZIENTI OSAS E VALUTA…

OSAS NAFLDSettore MED/10 - Malattie Dell'Apparato Respiratorio
researchProduct

Renal Function In European Patients Studied For Suspected Sleep Apnea. The European Sleep Apnea Database (ESADA)

2013

OSASSettore MED/10 - Malattie Dell'Apparato Respiratorio
researchProduct

Heredity and obesity-associated hypertension: impact of hormonal characteristics and left ventricular mass. J Hypertens

1995

OBJECTIVES: To investigate the influence of heredity on obesity-associated hypertension, we evaluated casual and 24-h blood pressure, left ventricular mass and some metabolic and hormonal measurements in normotensive obese subjects. DESIGN: Healthy, normotensive obese subjects (n = 81) with positive or negative family history of hypertension were studied. Both groups were also subdivided according to a positive or a negative family history of obesity. Accordingly, 45 obese subjects had a positive family history of hypertension, 25 of these having a positive (subgroup A) and 20 having a negative family history of obesity (subgroup B). The other 36 obese subjects had a negative family history…

Obesity Hypertension Family genetics renin-angiotensin systemSettore MED/09 - Medicina InternaSettore MED/45 - Scienze Infermieristiche Generali Cliniche E PediatricheSettore MED/11 - Malattie Dell'Apparato Cardiovascolare
researchProduct